Navigation Links
Landauer Names Douglas R. Gipson Chief Nuclear Executive
Date:5/29/2009

GLENWOOD, Ill., May 29 /PRNewswire-FirstCall/ -- Landauer, Inc. (NYSE: LDR) announced today that Douglas R. Gipson has been named Chief Nuclear Executive, effective May 15, 2009. Gipson will assume overall responsibility for Landauer's Global Nuclear Power Business. "We are very pleased to be able to name Doug to this critical position for Landauer. He has extensive industry experience at the executive and operating level and will be integral to Landauer's global nuclear power strategy. Doug is a tremendous addition to the Landauer management team," said Bill Saxelby, President and Chief Executive Officer.

Mr. Gipson is the recently retired Executive Vice President, Power Generation and Chief Nuclear Officer of Detroit Edison, a subsidiary of DTE Energy. Mr. Gipson was responsible for all of Detroit Edison's fossil and nuclear power generation facilities. His corporate duties further extended to responsibility for both DTE's industrial safety program and its environmental affairs, which included management of the environmental engineering and construction unit. In addition to his new role with Landauer, Gipson is currently the Chief Executive Officer of GenCo Asset Alliance. GenCo is a new company designed to meet the current large electrical motor needs of the utility sector. Additionally, Mr. Gipson is an Executive Consultant to URS/Washington Group's Nuclear Operations Power Business Unit. URS is working with several utilities and industry leading companies to develop the next generation of nuclear power plants.

In addition to his long tenure as DTE's Chief Nuclear Officer, Mr. Gipson combines a thorough understanding of nuclear technology and process with business and industry acumen. He has provided leadership and been an active voice in the U.S. nuclear industry, with extensive committee and board participation in professional organizations and universities, among them the American Nuclear Society, Nuclear Energy Institute, Institute of Nuclear Power Operations, Electric Power Research Institute, the Utilities Service Alliance, the Nuclear Management and Resources Council, and the University of Michigan.

Bill Saxelby continued, "This new position reflects the commitment and consistent execution against our long-term strategic plan, which focuses on: optimizing the core business, driving competitive growth and pursuing strategic expansion. Doug Gipson has 40 years of nuclear power experience in operating and executive management roles - his experience will be a significant asset relative to competitive growth and strategic expansion opportunities going forward. We are excited about having Doug strengthen our senior management team and are looking forward to his contribution."

About Landauer

Landauer is the leading provider of analytical services to determine occupational and environmental radiation exposure. For more than 50 years, the Company has provided complete radiation dosimetry services to hospitals, medical and dental offices, universities, national laboratories, and other industries in which radiation poses a potential threat to employees. Landauer's services include the manufacture of various types of radiation detection monitors, the distribution and collection of the monitors to and from clients, and the analysis and reporting of exposure findings.


'/>"/>
SOURCE Landauer, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Air Products Sells Three U.S. Healthcare Businesses to Landauer-Metropolitan
2. Landauer, Inc. Sets Date and Time for Announcement of Fiscal Second Quarter 2009 Results
3. Landauer, Inc. Declares Regular Cash Dividend
4. Landauer, Inc. Sets Date and Time for Announcement of Fiscal First Quarter 2009 Results
5. Landauer, Inc. Increases Regular Cash Dividend and Declares First Quarter Payment
6. Landauer, Inc. Sets Date and Time for Announcement of Fiscal Fourth Quarter and Full Year 2008 Results
7. Landauer, Inc. Declares Regular Cash Dividend
8. Landauer, Inc. Declares Regular Cash Dividend
9. Landauer, Inc. Reports Record Results for Second Quarter
10. Landauer, Inc. Declares Regular Cash Dividend
11. Landauer, Inc. Reports Strong Fiscal 2008 First Quarter Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2017)... ... , ... Providing broad access to life-saving drugs and rewarding the innovators who ... to address this problem. , That was the message from Dana Goldman, PhD, Leonard ... University of Southern California, who served as the keynote speaker for Western University of ...
(Date:4/21/2017)... ... April 21, 2017 , ... Evoke ... young adults, has kicked off its 4th annual Forum for Innovative Treatment Solutions ... is “Attachment Informed Therapy for Mental Health and Addiction.” , FITS’ 2017 ...
(Date:4/21/2017)... ... April 21, 2017 , ... The adage “Show, don’t ... the next project in the company’s esteemed VISION House demonstration project series. Manifesting the ... the amount of resources they need to live affordably and abundantly without unduly taxing ...
(Date:4/21/2017)... ... April 21, 2017 , ... Crossover Symmetry , ... , an active lifestyle company that provides Human Performance Training and education to ... offers, first responders, military officers and others in service through the development and ...
(Date:4/21/2017)... ... April 21, 2017 , ... Northern California Medical ... Care Spring Symposium on April 1, 2017 in Santa Rosa. This well-attended annual ... healthcare providers an opportunity to learn about cutting edge treatments, to collaborate, share ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... , April 19, 2017 Global Surgical Drainage ... are tubes used to remove excess liquid and air. ... pus, urine, bile or lymph. Surgical drains are used ... such as orthopedics surgery, cardiovascular surgery, neurosurgery, plastic surgery ... post-surgery to prevent accumulation of fluid e.g. blood or ...
(Date:4/19/2017)... -- Companion animal vaccines are ... such as canine, avian and feline. ... as Attenuated Live Vaccines, Conjugate Vaccines, Inactivated Vaccines, ... Vaccines. Attenuated live vaccines are derived from disease-causing ... been weakend under laboratory conditions. Conjugate vaccines are ...
(Date:4/18/2017)... Cogentix Medical, Inc. (NASDAQ: CGNT), a global medical device ... markets with innovative and proprietary products, will release financial ... after the market close on Tuesday, May 2, 2017. ... call and webcast to discuss its financial results the ... p.m. Eastern Time (3:30 p.m. Central Time). Darin ...
Breaking Medicine Technology: